Amount Raised
$10 Million
Round Type
Post-IPO Equity
La MesaBiotechnologyInvestors
Description
On October 27, 2026, Regen Biopharma, Inc. entered into a common stock purchase agreement with Coventry Enterprises, LLC. This agreement allows Coventry to purchase up to $10 million of common stock over 36 months, subject to certain conditions. Additionally, the company issued a $125,000 promissory note to Coventry as part of the agreement.
Quick answer
Regen Biopharma raised $10 Million in a Post-IPO Equity round, dated November 2, 2026. Investors: Coventry Enterprises, LLC. Regen Biopharma is based in La Mesa, California, United States.
- How much did Regen Biopharma raise?
- Regen Biopharma raised $10 Million in a Post-IPO Equity round on November 2, 2026.
- Who invested in Regen Biopharma?
- Coventry Enterprises, LLC is named as investors in this round.
- What does Regen Biopharma do?
- Regen Biopharma, Inc., incorporated in Nevada, operates within the biopharmaceutical industry, focusing on the development and commercialization of innovative therapies.
- Where is Regen Biopharma based and how big is it?
- Regen Biopharma is based in La Mesa, California, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Regen Biopharma that raised within 45 days of this round, from Fundz verified event records.
- Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
- XTPL raised $6.5M on November 13, 2026.
- BioWraptor raised $1.5M (Pre-Seed) on November 12, 2026.
- PAM2L Biotechnologies raised an undisclosed amount on November 12, 2026.
- Skribe Medical raised $1.6M (Pre-Seed) on November 12, 2026.
- Biomatter raised $18M (Series A) on November 12, 2026.
Who to call at Regen Biopharma, and when
A new round usually means Regen Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Regen Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Regen Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Regen Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Regen Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Regen Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.